RE: Occam's razor14 Sep 2022 04:48
Going back years when we speculated about moditope and how it could potentially play out SP-wise if it were indeed having a patient positive effect I'm sure we discussed the likelihood of we would see it in the SP before we heard it officially due to the nature of the patients ( very ill/terminal) and the way moditope worked in mouse models ( tumours dissolving within days of a therapeutic dose ) ..... I can't say this little rise is clear evidence of anything so specific, scancell has lots going on besides the modify trial but certainly, as I wrote previously it's unusual for this SP whose patterns we have gotten to know rather well over the years..... Of course, nothing would make me and no doubt all of us invested here happier to know modi 1 is doing the business it's what drew and kept most of us LTH here in the first place the potential of moditope being massive... only an RNS or a proper leak (media) will confirm it but it is great not to have my holding underwater anymore lol so may this rise continue and all kinds of positive newsflow arrive :)